Literature DB >> 29601821

Chronic Anterior Uveitis in Children: Psychosocial Challenges for Patients and Their Families.

Delana M Parker1, Sheila T Angeles-Han2, Annette L Stanton3, Gary N Holland4.   

Abstract

PURPOSE: To describe issues of concern to children with chronic anterior uveitis; to consider the psychological impact of chronic anterior uveitis on children's lives; and to understand the effect of a child's chronic illness on other family members.
DESIGN: Expert commentary.
METHODS: Author experiences were supplemented by a review of pertinent medical literature and by consideration of content from semi-structured, separate patient and parent interviews.
RESULTS: Vision loss and the fear of blindness are not the only stressors for children with chronic anterior uveitis and their families; of additional concern are the burdens of examinations and treatment regimens, as well as drug toxicities. Children with chronic anterior uveitis experience medical, academic, interpersonal, psychological, and developmental challenges. The impact of disease extends to other members of a patient's family as well; parents experience challenges in similar domains. Problems with adherence to medical regimens are common. Both the disease and its treatment affect quality of life, and can interfere with successful management of disease and transition to autonomy in adulthood, as reported for other chronic conditions. Coping processes vary greatly between different families.
CONCLUSIONS: Eye examinations and the rigors of long-term treatment often influence the psychosocial health of patients and families; physicians who are aware of these issues can help patients and families cope with chronic illness and may improve outcomes. Further psychosocial research to understand the experiences of children dealing with chronic anterior uveitis is warranted; this commentary can serve as a foundation for development of age- and disease-specific research questions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29601821      PMCID: PMC6788775          DOI: 10.1016/j.ajo.2018.03.028

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  37 in total

1.  Measuring the transition readiness of youth with special healthcare needs: validation of the TRAQ--Transition Readiness Assessment Questionnaire.

Authors:  Gregory S Sawicki; Katryne Lukens-Bull; Xiaoping Yin; Nathan Demars; I-Chan Huang; William Livingood; John Reiss; David Wood
Journal:  J Pediatr Psychol       Date:  2009-12-29

2.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

Authors:  J W Varni; M Seid; P S Kurtin
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

3.  Systemic juvenile rheumatoid arthritis: cognitive function and social adjustment.

Authors:  Reinhold Feldmann; Josef Weglage; Johannes Roth; Dirk Foell; Michael Frosch
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

4.  Quality-of-life metrics in pediatric uveitis.

Authors:  Sheila T Angeles-Han
Journal:  Int Ophthalmol Clin       Date:  2015

5.  Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study.

Authors:  Anthony C Gregory; John H Kempen; Ebenezer Daniel; R Oktay Kaçmaz; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne
Journal:  Ophthalmology       Date:  2012-10-11       Impact factor: 12.079

6.  The development of the LV Prasad-Functional Vision Questionnaire: a measure of functional vision performance of visually impaired children.

Authors:  Vijaya K Gothwal; Jan E Lovie-Kitchin; Rishita Nutheti
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

Review 7.  Special considerations in the evaluation and management of uveitis in children.

Authors:  Gary N Holland; E Richard Stiehm
Journal:  Am J Ophthalmol       Date:  2003-06       Impact factor: 5.258

8.  Psychological functioning of children with insulin-dependent diabetes mellitus: a longitudinal study.

Authors:  M Kovacs; S Iyengar; D Goldston; J Stewart; D S Obrosky; J Marsh
Journal:  J Pediatr Psychol       Date:  1990-10

Review 9.  Parent-child agreement across child health-related quality of life instruments: a review of the literature.

Authors:  Penney Upton; Joanne Lawford; Christine Eiser
Journal:  Qual Life Res       Date:  2008-06-03       Impact factor: 4.147

10.  Impact of pediatric vision impairment on daily life: results of focus groups.

Authors:  Dawn K Decarlo; Gerald McGwin; Martha L Bixler; Jan Wallander; Cynthia Owsley
Journal:  Optom Vis Sci       Date:  2012-09       Impact factor: 1.973

View more
  3 in total

1.  Development of a Nationally Agreed Core Clinical Dataset for Childhood Onset Uveitis.

Authors:  Ameenat Lola Solebo; Salomey Kellett; Jugnoo Rahi; Reshma Pattani; Clive Edelsten; Andrew D Dick; Alastair Denniston
Journal:  Front Pediatr       Date:  2022-06-21       Impact factor: 3.569

2.  Comprehensive Assessment of Quality of Life, Functioning, and Mental Health in Children With Juvenile Idiopathic Arthritis and Noninfectious Uveitis.

Authors:  Joseph McDonald; Amy Cassedy; Mekibib Altaye; Jennifer Andringa; Ashley M Cooper; Carolyn Drews-Botsch; George Engelhard; Theresa Hennard; Gary N Holland; Kirsten Jenkins; Scott R Lambert; Jessi Lipscomb; Courtney McCracken; Deborah K McCurdy; Najima Mwase; Sampath Prahalad; Jessica Shantha; Erin Stahl; Virginia Miraldi Utz; A Adrienne Walker; Steven Yeh; Sheila T Angeles-Han
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-06-08       Impact factor: 5.178

Review 3.  Pediatric uveitis: Role of the pediatrician.

Authors:  Abhay Shivpuri; Inga Turtsevich; Ameenat Lola Solebo; Sandrine Compeyrot-Lacassagne
Journal:  Front Pediatr       Date:  2022-08-01       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.